Fundraising Fox

GENERAL INCEPTION

Accelerator

Palo Alto · Pre-Seed–Seed · 39 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

General Inception operates as a business co-founder for technical entrepreneurs building science-based companies. The firm provides comprehensive support across company formation, product-market development, and fundraising by leveraging its networks of talent, customers, and institutional investors. Its model emphasizes solving core startup challenges through legal, financial, operational, and strategic guidance while building an interconnected ecosystem of portfolio companies that can access new technologies and markets.

Source: firm website, verified Jul 21, 2026.

Stage
Pre-Seed–Seed
HQ
Palo Alto, US
Leads rounds
Follows
Instruments
Equity
Tracked investments
38

Team · 39 people

from the firm's website
Paul Conley· Chairman & CEO
Brad Nelson· Life Science Tools & Dx
Chris Hoppe· Engineered Biology
Francois Valencony· Chief Business Officer
Neil Kubica· Therapeutics
Sara Jones· Engineered Biology
Venkat Reddy· Chief Science Officer
Vikram Chaudhery· President & COO
Adam Weischhaus· Executives in Residence
Alan Dance· Executives in Residence
Arunan Skandarajah· Executives in Residence
Autumn Lee· Chief of Staff
Brad Crutchfield· Executives in Residence
Byron Hewett· Executives in Residence
Carol Tillis· Finance
Chris Barbazette· Executives in Residence
David Ferrick· Executives in Residence
David Klein· Executives in Residence
Elisabeth Gardiner· Strategic Advisor
Elodie Dormes· Business Development
Greg Timblin· Executives in Residence
Ingrid Caton· Program Manager
Jeff Caputo· Executives in Residence
Jeff Rieger· Executives in Residence
John Leonard· Executives in Residence
John Saunders· Business Operations
Kelli Zimmerman· Administrative Staff
Larry Burgess· Executives in Residence
Laure Bouchez· Executives in Residence
Loïc Vincent· Strategic Advisor
Marsha Hartman· Executives in Residence
Martin Verhoef· Executives in Residence
Michael Wood· Executives in Residence
Peter Seufer-Wasserthal· Executives in Residence
Rolando Brawer· Executives in Residence
Samie Wolfe· Administrative Staff
Sanket Agrawal· Executives in Residence
Soraia Silva Romão· Administrative Staff
Tim Richardson· Strategic Advisor

What they invest in

from 2 of 38 portfolio companies

Biotech ×2Deep Tech ×2Medical Devices ×1New Materials ×1

HQs:United States×4

Investments · 38 tracked

founders shown can be your intro path
Abbelightabbelight.com
Accelmedx

Linking CRISPR to single cell genomics with DNA-RAM

Alidabioalidabio.comin
Axoiyabioaxoiyabio.com
Base Pair Biology
Basilardbiotechbasilardbiotech.comin
Biocellisbiocellis.comin
Breathwalk

Novel clinical sample collection from breath

Clearcutsurgicalclearcutsurgical.comin
Constructive Bioconstructive.bioin𝕏

Constructive develops synthetic biology technology using recoded genomes and engineered tRNAs to incorporate novel chemical building blocks into proteins, enabling new therapeutics, materials, and manufacturing applications.

BiotechDeep TechNew Materials

Cryoveritascryoveritas.com
Detectivebiodetectivebio.com
Dyno Therapeutics

Enabling genetic medicine through next generation, cell-specific delivery

Elenihealthelenihealth.comin
Ennovatetxennovatetx.com
Exodigmexodigm.com
Generalinceptiontxgeneralinceptiontx.com
Hermesbioscienceshermesbiosciences.comin

Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.

BiotechDeep TechMedical Devices

Igniter Management

Bridging the gap between conceptualization and realization

Inapillinapill.com
Jounce Therapeutics

Targeting RNA modifying enzymes in autoimmunity

Kindbody

At-home reproductive health management for women

Nema Therapeutics

Single-molecule protein sequencing for unbiased high depth proteomics

Originpeptidesoriginpeptides.comin
Partillionpartillion.comin
Pharmacelerapharmacelera.comin𝕏
Planetsmartplanetsmart.coin
Roxbiosensroxbiosens.com
Scellgenscellgen.com
Surftherapeuticssurftherapeutics.comin
Switchbacksysswitchbacksys.comin
Synthbiomesynthbiome.com
Tactiletxtactiletx.com
Taviratxtaviratx.comin
Trenchtxtrenchtx.com
Wespranwespran.comin
XCUR Therapeutics

Developing a vein-to-vein autologous cell therapy manufacturing system

Xeraenergyxeraenergy.com

Board seats · per SEC filings · 4

what is this? ⓘ
SimBioSys, Inc.SEC filing

$8M raise · filed Jan 2025 · via Vikram Chaudhery

Switchback Systems, Inc.SEC filing

$15M raise · filed Aug 2024 · via Craig Asher

Glyphic Biotechnologies, Inc.SEC filing

$52.9M raise · filed Feb 2024 · via Craig Asher

BRAINBOX SOLUTIONS, INC.SEC filing

$18.5M raise · filed Nov 2023 · via Vikram Chaudhery

Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

What stage does GENERAL INCEPTION invest at?
GENERAL INCEPTION invests at the Pre-Seed, Seed stages.
What sectors does GENERAL INCEPTION focus on?
GENERAL INCEPTION focuses on Biotech, Deep Tech, Medical Devices, Sector Agnostic.
Where is GENERAL INCEPTION located?
GENERAL INCEPTION is headquartered in Palo Alto, US.
Does GENERAL INCEPTION lead rounds?
GENERAL INCEPTION typically participates in rounds rather than leading them.

Similar investors

Featured in lists